BRAF V600E Detection in Liquid Biopsies from Pediatric Central Nervous System Tumors

Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies

(2019) Samuel D. Abbou et al.   PEDIATRIC BLOOD & CANCER

Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

(2019) Stephanie A. Toll et al.   Oncotarget

Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges

(2019) Benjamin T. Himes et al.   Frontiers in Oncology

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

(2019) Adrienne Boire et al.   NEURO-ONCOLOGY

Childhood brain tumors: current management, biological insights, and future directions

(2019) Ian F. Pollack et al.   Journal of Neurosurgery-Pediatrics

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol

(2019) Laure Sorber et al.   Cancers

Liquid Biopsy for the Detection of Resistance Mechanisms in NSCLC: Comparison of Different Blood Biomarkers

(2019) Luigi Pasini et al.   Journal of Clinical Medicine

Circulating cell-free tumor DNA analysis in pediatric cancers

(2019) Daniel Andersson et al.   MOLECULAR ASPECTS OF MEDICINE

BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors

(2019) Karisa C. Schreck et al.   Cancers

BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers

(2018) Jaquelyn N. Sanchez et al.   DRUGS

Extracellular vesicles compartment in liquid biopsies: Clinical application

(2018) Noemi Garcia-Romero et al.   MOLECULAR ASPECTS OF MEDICINE

Recent Progress in Pathology and Genetics of Pilocytic and Pilomyxoid Astrocytomas

(2018) Cristine Ding et al.   Balkan Medical Journal

Tumors of the Central Nervous System in Children and Adolescents

(2018) Michael C. Frühwald et al.   Deutsches Arzteblatt International

CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response

(2018) Stefanie Stallard et al.   Acta Neuropathologica Communications

Liquid biopsy: novel technologies and clinical applications

(2018) Natalie Reimers et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review

(2018) Veronika Vymetalkova et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas

(2017) Alvaro Lassaletta et al.   JOURNAL OF CLINICAL ONCOLOGY

The Blood Brain Barrier and BRAF inhibitors: Implications for patients with melanoma brain metastases

(2017) Keiran S.M. Smalley et al.   PHARMACOLOGICAL RESEARCH

Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma

(2017) Wenyong Long et al.   Frontiers in Pharmacology

Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma

(2017) Tina Y. Huang et al.   Acta Neuropathologica Communications

Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review

(2016) Libby Infinger et al.   Current Neuropharmacology

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

(2016) Felix Behling et al.   Diagnostic Pathology

Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma

(2016) Jamie Tisnado et al.   JOURNAL OF CHILD NEUROLOGY

Targeting oncogenic BRAF and aberrant MAPK activation in the treatment of cutaneous melanoma

(2015) Matteo S. Carlino et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study

(2015) Heidy Sierra et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

(2015) Leticia De Mattos-Arruda et al.   Nature Communications

Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

(2014) Francesca del Bufalo et al.   Journal of Translational Medicine

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

(2014) Alain R Thierry et al.   NATURE MEDICINE

First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study

(2013) J-Y Douillard et al.   BRITISH JOURNAL OF CANCER

The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis

(2012) Gholamreza Safaee Ardekani et al.   PLoS One

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

(2011) Genevieve Schindler et al.   ACTA NEUROPATHOLOGICA

Evaluation of a Droplet Digital Polymerase Chain Reaction Format for DNA Copy Number Quantification

(2011) Leonardo B. Pinheiro et al.   ANALYTICAL CHEMISTRY